This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

MultiPlan, insurers file replies in support of dismissing US antitrust claims

( April 3, 2025, 14:26 GMT | Official Statement) -- MLex Summary: MultiPlan and health insurers filed relies in support of their motions to dismiss US claims that they conspired to reduce the reimbursements they pay to healthcare providers for out-of-network healthcare services, saying the opposition only seeks to deflect. “Rather than answering defendants’ arguments and pointing to well-pleaded factual allegations that establish their single antitrust claim, plaintiffs instead ignore or contort their own allegations, their missing allegations, and the applicable caselaw. Most strikingly, plaintiffs concede that there is more than a decade’s worth of caselaw dismissing similar antitrust claims against [managed care organizations] based on allegations that they have used the same third-party data sources to allegedly suppress reimbursements to out-of-network providers,” they said.See attached files. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login